Showing 2,676 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy

Editor's pick
MarketWatch (press release)
8 May 2012
Hepatitis & HIV

Liver transplants in HIV-HCV co-infection—results from a U.S. study

Editor's pick
CATIE
8 May 2012
New & experimental hepatitis C treatment

Bristol-Myers Missing Hep C Data Raises Red Flags, May Boost Gilead, Idenix

Editor's pick
The Street
8 May 2012
Treatment outcomes & life expectancy

Co-infection with hepatitis C increases mortality risk by 50% for patients with AIDS

News
6 May 2012
Hepatitis C transmission & prevention

Hepatitis C a latent legacy of baby boomers' youth

Editor's pick
Los Angeles Times
2 May 2012
Cancer

Brivanib did not improve overall liver cancer survival, but did show anti-tumour activity

News
30 April 2012
Hepatitis C transmission & prevention

Scotland: Quality Indicators for Hepatitis C

Editor's pick
Health Care Improvement Scotland
30 April 2012
New & experimental hepatitis C treatment

GS-7977 with interferon/ribavirin cures most treatment-naive hepatitis C patients in 12 weeks

News
30 April 2012
Pharmaceutical industry

Gilead Sciences 1Q profit down on Pharmasset costs

Editor's pick
CBS News
27 April 2012
New & experimental hepatitis C treatment

US: do not mix Merck hepatitis pill with HIV drugs

Editor's pick
Reuters
27 April 2012
Treatment outcomes & life expectancy

Chronic hepatitis B infection associated with twice the risk of liver-related death compared to hepatitis C

News
27 April 2012
Hepatitis C transmission & prevention

Incidence of hepatitis C re-infection and clearance may be understimated

News
26 April 2012
New & experimental hepatitis C treatment

NICE publishes final guidance on two new drugs for chronic hepatitis C

Editor's pick
NICE press release
25 April 2012
Hepatitis & HIV

Family history ups liver cancer risk

Editor's pick
Times of India
25 April 2012
New & experimental hepatitis C treatment

Telaprevir May Cause Severe Cutaneous Eruptions

Editor's pick
Medscape (requires free registration)
24 April 2012
New & experimental hepatitis C treatment

Abbott interferon-free HCV combinations show early promise in untreated patients

News
23 April 2012
New & experimental hepatitis C treatment

Grading Hep C Stocks Exiting EASL - The future of hepatitis C therapy belongs to interferon-free regimens

Editor's pick
The Street
23 April 2012
New & experimental hepatitis C treatment

Boceprevir a useful option for patients who did not respond to earlier course of hepatitis C therapy

News
23 April 2012
New & experimental hepatitis C treatment

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
New & experimental hepatitis C treatment

Achillion Clarifies End of Treatment Data From Phase 2a Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
New & experimental hepatitis C treatment

Adding TMC435 boosts response for difficult-to-treat hepatitis C patients

News
23 April 2012
New & experimental hepatitis C treatment

Hepatitis C drug alisporivir is effective, but pancreatitis a concern

News
23 April 2012
Hepatitis C treatment side-effects

Telaprevir and boceprevir show high rate of serious side-effects in hepatitis C patients with urgent need of treatment

News
20 April 2012
New & experimental hepatitis C treatment

Hepatitis C meds GS-7977, daclatasvir and asunaprevir look good in interferon-free combos

News
20 April 2012